Pharmacytimes: Condition Center: Hepatitis C Hepatitis C en-us Thu, 24 May 2018 12:32:19 UTC Thu, 24 May 2018 12:32:19 UTC New Drugs Introduced in 2017: Part 3 Genetic Diseases, Hematology, and Liver Disease This year, the FDA is on pace to approve about 38 new medications. Here is a look at 4 of those. 9:19 PM, Wed October 18, 2017 Mavyret for Hepatitis C: What Pharmacists Should Know There are several key therapeutics areas of which to be aware. 5:11 AM, Tue October 3, 2017 Merck Discontinues 2 HCV Clinical Programs This decision was made based on a review of available phase 2 efficacy data and in consideration of the evolving marketplace and the growing number of treatment options available for patients with chronic HCV infection, including elbasvir and grazoprevir (Zepatier). 11:45 AM, Sat September 30, 2017 Vosevi for Hep C: What Pharmacists Should Know This article highlights several key therapeutics areas with Vosevi that every pharmacist should know. 9:27 PM, Wed September 6, 2017 FDA Approves Hepatitis C Drug Officials with the FDA have announced the approval of glecaprevir and pibrentasvir (Mavyret, AbbVie Inc) for hepatitis C.&nbsp; 4:40 PM, Thu August 3, 2017 FDA Approves Hep C Drug &nbsp;Vosevi is a fixed-dose, combination tablet containing&nbsp;sofosbuvir&nbsp;and velpatasvir, as well as the new drug voxilaprevir, according to a press release.<br /> &nbsp;<br /> <br /> <br /> &nbsp; 5:10 PM, Tue July 18, 2017 Hepatitis C: Oral Direct-Acting Antivirals Are Standard of Care <p>Chronic hepatitis C virus (HCV) infection, estimated to affect up to 4 million Americans, is a leading cause of end-stage liver disease, hepatocellular carcinoma, and liver transplant.&nbsp;</p> 2:11 PM, Wed May 17, 2017 CDC Report Focuses on Slowing Hepatitis C Infection Rate Hepatitis C virus infection rates are the highest in 15 years, according to recent data released by the CDC. 9:30 AM, Tue May 16, 2017 FDA Approves 2 Hepatitis C Drugs for Use in Pediatric Patients The FDA approved supplemental applications for Sovaldi (sofosubuvir) and Harvoni (ledipasvir and sofosbuvir), marketed by Gilead Sciences Inc., to treat hepatitis C virus (HCV) in pediatric patients.&nbsp; 11:37 AM, Fri April 7, 2017 Hepatitis C Regimen Can Cause Cataracts An adverse effect with interferon-ribavirin Hepatitis C therapy that does not stop after discontinuation. 2:03 AM, Mon April 3, 2017 Will Hepatitis C Virus Medication Costs Drop in the Years Ahead? Proposals such as allowing Medicare price negotiation, capping out-of-pocket drug costs, importing drugs, and limiting manufacturer&rsquo; spending on patient marketing could all result in lower HCV drug costs. 5:17 PM, Wed February 8, 2017 Investigational Hepatitis C Drug Granted Priority Review &nbsp;<br /> The FDA has accepted AbbVie&rsquo;s New Drug Application (NDA) for and granted priority review to its investigational, pan-genotype regimen of glecaprevir/pibrentasvir (G/P).&nbsp; 2:22 PM, Fri February 3, 2017 ISMP Report Questions Safety of Hepatitis C Drugs A recently-published Institute for Safe Medication Practices (ISMP) report details updated concerns about newer drugs used to treat hepatitis C virus (HCV).&nbsp; 11:44 AM, Fri January 27, 2017 Epclusa for Hep C: What Pharmacists Should Know This fixed-dose combination of sofosbuvir and velpatasvir is indicated to treat chronic HCV genotypes 1-6. 9:38 PM, Wed January 4, 2017 Studies in Virology Every Pharmacist Should Know Over the years, a number of landmark clinical studies in virology have been published, shaping how we treat the disease today. 10:35 PM, Tue December 27, 2016 These Treatments Improve PHT in Patients With HIV and HCV Patients who have human immunodeficiency virus (HIV) infection are at elevated risk for HCV. 3:04 PM, Tue December 13, 2016 Declining Hepatitis C Sales Reports show that sales and revenue from Hepatitis C treatments are declining. What does this mean for patients? 10:28 PM, Wed November 16, 2016 Pharmacist Charged for Hepatitis C Drug Fraud A former Clinical Pharmacy Manager at a Walgreens specialty pharmacy pleaded guilty to health care fraud crimes committed between October 2014 and April 2016. 8:00 AM, Thu October 27, 2016 5 Highlights from the Pharmacy World This Week In case you missed it, here's the hottest news in pharmacy this week: 11:13 PM, Thu October 6, 2016 Trouble on the Horizon for Gilead's HCV Market Hold Gilead Sciences maker of hepatitis C virus blockbusters Sovaldi, Harvoni, and, most recently, Epclusa has come under increasing scrutiny for declining revenues, both in the near-term and beyond. 3:05 AM, Fri September 2, 2016